[Asia Economy Reporter Minji Lee] BioPlus announced on the 13th that it has signed a trust contract with Korea Investment & Securities for the acquisition of its own shares worth 5 billion KRW. The company stated, "This is to stabilize the stock price and enhance shareholder value."



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing